News for 'Good Manufacturing Practice'

UK regulator's import alert on Wockhardt

UK regulator's import alert on Wockhardt

Rediff.com6 Jul 2013

According to the chairman, there will be an annual loss of Rs 100 crore due to the MHRA alert on Waluj plant

Rural two-wheeler demand roars back to life in first half of 2024

Rural two-wheeler demand roars back to life in first half of 2024

Rediff.com22 Jul 2024

The two-wheeler segment has shown signs of recovery in the first half (H1) of calendar year (CY) 2024, largely driven by improving performance in rural areas. According to the Federation of Automobile Dealers Associations, rural contribution to two-wheeler sales surged by 57-60 per cent in the April-June quarter of 2024-25, indicating a rising demand in these regions. Experts believe that this trend will continue, supported by a favourable monsoon season and government initiatives aimed at rural development.

4 Indian drug firms recall products in US market

4 Indian drug firms recall products in US market

Rediff.com15 Nov 2020

Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest enforcement report by the US Food and Drug Administration (USFDA). While Marksans Pharma is recalling diabetes drug, Zydus Pharmaceuticals (USA) is recalling drug which is used to reduce stomach acid. Similarly, Aurobindo Pharma (USA) is recalling pain relieving drug, while Jubilant Cadista is recalling a medication used to treat schizophrenia.

PIX: People across country celebrate Diwali with pomp

PIX: People across country celebrate Diwali with pomp

Rediff.com31 Oct 2024

Keeping up his tradition of celebrating the festival with soldiers, Prime Minister Narendra Modi visited Sir Creek near the Indo-Pak border in Gujarat's Kutch district and offered sweets to jawans.

Piyush Goyal not against e-commerce platforms, but...

Piyush Goyal not against e-commerce platforms, but...

Rediff.com22 Aug 2024

A day after lambasting e-commerce players for predatory pricing, Union Commerce Minister Piyush Goyal on Thursday said he is not against online platforms but India wants such entities to be "fair and honest" in their conduct. Speaking with reporters in the financial capital, the outspoken Union minister said the rule of the law should be followed in letter and spirit, and made it clear that consumer preferences should not be influenced by algorithms.

'Jobs Have Evolved, Skill Sets Haven't'

'Jobs Have Evolved, Skill Sets Haven't'

Rediff.com29 Aug 2024

'India has a skill shortage of 56%.' 'This is a very interesting paradox -- the unemployment rate is 6% to 7%, and at the same time 20% of those qualified are unemployed.'

Mobile phones to cost less as govt cuts import duty

Mobile phones to cost less as govt cuts import duty

Rediff.com31 Jan 2024

A day ahead of the interim Budget, India slashed import duty on spare parts, like battery cover, lens and SIM socket, used in mobile phone manufacturing to 10 per cent, from 15 per cent. The duty cut is aimed at boosting local production and exports, as well as reducing prices in local markets. The finance ministry on January 30, notified the cut in duty on all goods for use in manufacture of cellular mobile phones to 10 per cent.

'BTech From IIT-K. Yet To Get A Job'

'BTech From IIT-K. Yet To Get A Job'

Rediff.com26 Jul 2024

Connect with professionals in your field through LinkedIn, industry events and workshops. Attend job fairs, conferences and meetups to expand your network. Apply for internships or short-term projects to gain practical experience, suggests rediffGURU Aasif Ahmed Khan.

Another Indian COVID-19 vaccine candidate gets nod for human trial

Another Indian COVID-19 vaccine candidate gets nod for human trial

Rediff.com3 Jul 2020

Zydus plans to initiate the clinical trials of ZyCoV-D in July 2020 across multiple sites in India. In animal studies the vaccine was found to elicit a strong immune response in multiple animal species like mice, rats, guinea pigs and rabbits.

The 'manufacturing nationalism' of Modi and Trump

The 'manufacturing nationalism' of Modi and Trump

Rediff.com5 Jan 2017

Both have made factory jobs the centre of their economic agendas. Kanika Datta explains the practical limits to their ambitions.

From Godrej to Tata, India Inc begins breaking the diversity mould

From Godrej to Tata, India Inc begins breaking the diversity mould

Rediff.com27 Nov 2023

In a move towards gender inclusion, Tamil Nadu has partnered Godrej Consumer Products (GCPL) to offer a 5 per cent job reservation for LGBTQAI+ and people with disabilities at GCPL's upcoming fast-moving consumer goods manufacturing unit in Thiruporur in Chengalpattu district. According to industry experts and activists, while companies acknowledge transgender communities, this is the first time the entire spectrum of gender minorities, including lesbian, gay, bisexual, transgender, queer/questioning (one's sexual or gender identity), asexual and intersex, is receiving such a notable share of job participation in the private sector while signing memoranda of understanding with states.

WHO wrong in linking Gambia kids deaths to Indian cough syrups: DCGI

WHO wrong in linking Gambia kids deaths to Indian cough syrups: DCGI

Rediff.com16 Dec 2022

In the letter, Somani said the samples of four made-in-India cough syrups linked to the deaths of 66 children in Gambia which were tested in government laboratory here were found to be complying with specifications and not to have been contaminated with DEG or EG according to the test reports.

Indian regulator also scans Ranbaxy

Indian regulator also scans Ranbaxy

Rediff.com20 Sep 2013

The move comes in the wake of many facilities of Ranbaxy in India being barred by the US Food and Drugs Administration for supplying medicines to the US.

Sun Pharma unit recalls mutiple lots of capsules from US

Sun Pharma unit recalls mutiple lots of capsules from US

Rediff.com15 Aug 2014

The recalled drug bottles were distributed by Caraco Pharmaceutical Laboratories, Ltd in the US while manufactured in India by Sun Pharmaceutical Industries Ltd.

'He Was Not An 'I' Man At All'

'He Was Not An 'I' Man At All'

Rediff.com23 Oct 2024

'He was a practical person who ensured that he thought about the common man, animals, the fact that they have a life and they have to be respected.'

How Haryana Win Revives Modi Aura

How Haryana Win Revives Modi Aura

Rediff.com17 Oct 2024

BIf you know this BJP, it will now go forward to Jharkhand and Maharashtra as if June 2024 never happened, notes Shekhar Gupta.

US FDA conducts surprise inspection of Dr Reddy's Vizag plant

US FDA conducts surprise inspection of Dr Reddy's Vizag plant

Rediff.com20 Nov 2014

The FDA has been tightening its monitoring of Indian pharma majors over compliance issues. Surprise plant inspections and import alerts have been frequent outcomes

Quality Control Orders: What does this mean for domestic industry?

Quality Control Orders: What does this mean for domestic industry?

Rediff.com25 Apr 2024

From toys, footwear and furniture to insulated flasks, smart meters, and air coolers - the Central government over the last decade has mandated higher standards for production and imports of such items. Sample this: Till 2014, there were 14 Quality Control Orders (QCOs) covering 106 products. By the latest count, there are 156 QCOs on 672 products.

Atmanirbhar and PLI: Why Modi's ambitious manufacturing targets are unachievable

Atmanirbhar and PLI: Why Modi's ambitious manufacturing targets are unachievable

Rediff.com12 Mar 2021

Recently, Prime Minister Narendra Modi met over 40 CEOs across broad swathes of industry, ranging from makers of mobile devices, auto components, food products to telecom networking equipment and pharmaceuticals. The agenda: To discuss how to make India an integral part of the global supply chain. The focus of the discussion would be the much touted yet not so well understood production-linked incentive scheme (PLI), the centrepiece of the government's drive to massively boost the manufacturing sector. To do so, the government has created a war chest of over Rs 197,000 crore to be paid out as incentives to over 14 industries in five years. There are three objectives to the scheme, two explicitly stated, one implied.

Novovax Covid vaccine likely to get nod in India ahead of US

Novovax Covid vaccine likely to get nod in India ahead of US

Rediff.com18 Aug 2021

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending on DCGI approvals.

Sun Pharma hit by FDA ban on Gujarat plant, shares fall

Sun Pharma hit by FDA ban on Gujarat plant, shares fall

Rediff.com13 Mar 2014

Recently, Ranbaxy and Wockhardt too were hauled up.

Exports to EU from Ranbaxy's two plants to remain suspended

Exports to EU from Ranbaxy's two plants to remain suspended

Rediff.com9 Apr 2014

Exports from Ranbaxy plants at Toansa and Dewas to Europe will remain suspended as probes are continuing even as Indian authorities have withdrawn the certification of manufacturing standards from one of the units, European health regulator EMA said today.

Profit might be hit in FY16: Sun Pharma

Profit might be hit in FY16: Sun Pharma

Rediff.com21 Jul 2015

4 Ranbaxy facilities in India have been barred from exporting to US.

COVID-19 Vaccine: 4 months from lab to jab

COVID-19 Vaccine: 4 months from lab to jab

Rediff.com8 Jun 2021

'Almost 70 per cent production time of a vaccine is dedicated to quality control, which is done through several hundred tests.'

Ranbaxy recalls some batches of generic Lipitor in latest quality blow

Ranbaxy recalls some batches of generic Lipitor in latest quality blow

Rediff.com10 Mar 2014

The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.

Modi wins 3rd term, but it will be a different NDA now

Modi wins 3rd term, but it will be a different NDA now

Rediff.com4 Jun 2024

Despite the upbeat statement, the party is expected to reflect on what caused the sharp fall in its numbers. It is expected to win about 240 seats against the 303 it had won in 2019.

No advance payments, says Bharat Biotech as Brazil suspends deal

No advance payments, says Bharat Biotech as Brazil suspends deal

Rediff.com30 Jun 2021

"We suspended the deal as a simple preventive measure, since there are complaints that could not be explained well by the complainant, so we opened a preliminary investigation last week," said Rosario, head of the Federal Comptroller General.

Wockhardt medicines banned in Europe

Wockhardt medicines banned in Europe

Rediff.com11 Jul 2013

Its Waluj manufacturing facility in Maharashtra failed to meet the good manufacturing norms prescribed by the UK drug regulator.

Indian 2 Review: Kamal Haasan Elevates Overwritten Sequel

Indian 2 Review: Kamal Haasan Elevates Overwritten Sequel

Rediff.com12 Jul 2024

The saving grace of Shankar's expanded universe is the masterful precision with which Kamal Haasan drops himself into a messy setup, only slightly to elevate the pulpy tendencies of Shankar's vision, observes Arjun Menon.

HCL Tech Q4 net profit flat at Rs 3,986 cr

HCL Tech Q4 net profit flat at Rs 3,986 cr

Rediff.com26 Apr 2024

India's third largest IT company HCL Technologies on Friday reported a flat year-on-year growth in net profit in the March quarter at Rs 3,986 crore. However, the company posted an 8.4 per cent decline in net profit on a sequential basis, amid rising employee cost and tightening IT spends around the world. The company described the performance as "decent" in view of the global macroeconomic conditions.

Ram Teri Ganga Maili

Ram Teri Ganga Maili

Rediff.com12 Jun 2024

Six decades and more later, we are now captives of our identities. Every poll is based on elaborate calculations of electability of candidates on the basis of their castes and other narrow definers. That, along with voter promiscuity, is what defines our political culture, which remains stubbornly resistant to any change, asserts Shreekant Sambrani.

The Most Memorable Goodbye Turns 50

The Most Memorable Goodbye Turns 50

Rediff.com27 Aug 2024

'Garm Hava understands that the scorching, hate-filled, doubt-filled affair between Hindus and Muslims is our national love affair.' Sreehari Nair revisits M S Sathyu's classic film, featuring the incomparable Balraj Sahni at his finest in his final role.

'Aim to make FAME scheme more transparent'

'Aim to make FAME scheme more transparent'

Rediff.com14 Apr 2023

'The aim is also to probe how the ministry and testing agencies made negligence in examining these OEMs, so that such negligence is avoided in the future.'

Campus Placements At IITs Getting Tough

Campus Placements At IITs Getting Tough

Rediff.com8 Jul 2024

Nearly 40 per cent of IITians sitting for placements in 2024 are yet to receive job offers, showing a doubling of the 'unplaced' in the last three years from 19 per cent in 2021-2022 to 38 per cent in 2023-2024.

Delhi air improves, but still in 'poor' category

Delhi air improves, but still in 'poor' category

Rediff.com24 Oct 2023

The city's average air quality index (AQI) stood at 220 at 12 noon, improving from 263 at 4 pm on Monday.

Now, Hospira under US FDA's lens

Now, Hospira under US FDA's lens

Rediff.com23 Dec 2013

Formal warning to Indian unit of deficiencies noted during inspection at facility near Chennai; firm says will remedy

Before You Invest ESG Funds, Read This

Before You Invest ESG Funds, Read This

Rediff.com19 Mar 2024

An allocation to ESG theme funds can bring down the overall risk of an equity portfolio. Investors with long-term financial goals, such as retirement, should not ignore sustainable investing.

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Rediff.com27 Feb 2014

Whistle-blower Dinesh Thakur will speak on Made-in-India drugs at an event in Washington.

Lapses by some pharma cos overshadowed good things: FDA chief

Lapses by some pharma cos overshadowed good things: FDA chief

Rediff.com12 Feb 2014

On her maiden visit to India, US Food and Drug Administrator Margaret A Hamburg has said recent lapses in quality by a handful of pharma companies has overshadowed the good things done by other Indian companies, who emphasise on quality products and practices.

After ban on drug facilities, US regulator comes calling

After ban on drug facilities, US regulator comes calling

Rediff.com10 Feb 2014

Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.